Farragut Invests in Amglo Kemlite Laboratories, Inc.

WASHINGTON, D.C. – Farragut Capital Partners, Inc. is pleased to announce the closing of an investment in Amglo Kemlite Laboratories, Inc. (“Amglo”).  Farragut invested subordinated debt and made an equity co-investment to support the acquisition of Amglo by NewCastle Partners, LLC.  The Amglo transaction marks the fifth investment of the firm’s second SBIC Fund.

Founded in 1935 and based in Bensenville, Illinois, Amglo is a specialty manufacturer of flash and non-flash xenon and halogen lamps that are used in a range of niche applications, including aircraft runway lamps, aircraft-mounted navigation lights, railroad headlamps, emergency vehicle lamps, obstruction lamps, aesthetic laser lamps and medical and industrial lamps.  Amglo sells these products to OEM manufacturers, MRO suppliers, and other resellers and distributors.

Rob Hagerty led the transaction for Farragut.  “Amglo has a long history of innovation and a strong presence in its many end-markets,” he said.  “Our team has also known Jack Lowden at NewCastle for a long time, and we’re excited to have the opportunity to partner on this investment.”

Jack Lowden of NewCastle Partners commented, “We are pleased to be partnering with Amglo CEO Grant Hyland, his executive management group, and Farragut Capital Partners.  Operating as an independent company, Amglo will have an opportunity to further capitalize on growth opportunities within its end markets, internally as well as by corporate and product line acquisitions.”